Inagene launches GLP-1 Insights Program combining genetic insights with registered dietitian support to help Canadians understand their genetic response to weight management and diabetes medications Markets 5 h ago
VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results Markets 2 d ago also on VIK VKTX
Why Do People Regain Weight After Stopping GLP-1s Like Ozempic? Researchers Think They’ve Solved the Mystery Markets 12 h ago
‘Game-changer’ GLP-1s could fix America’s obesity crisis—but 2 inequalities stand in the way Markets 35 d ago
GLP-1 Drugs Put $149 Billion in Food Spending at Risk. So Far, the Biggest Loser Isn’t Candy Markets 2 d ago
Structure Therapeutics Inc. (GPCR) Discusses Positive Clinical Data Updates for Oral Small Molecule Amylin and GLP-1 Programs in Chronic Weight Management Transcript Markets 15 d ago also on GPCR
Could Doctors Predict Hair Loss Before Prescribing GLP-1 Drugs? Researchers See a Path Markets 20 d ago
Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity Markets 22 d ago also on LLY
Fractyl Health, Inc. (GUTS) Discusses Commercialization Strategy for Investigational Post-GLP-1 Procedural Therapy Transcript Markets 23 d ago also on GUTS
Insurers Are Pulling Back From GLP-1 Drugs. The FDA Just Handed Eli Lilly Its Best Weapon Yet Markets 23 d ago also on LLY